Prandin

Prandin is a brand name of repaglinide, approved by the FDA in the following formulation(s):

PRANDIN (repaglinide - tablet; oral)

• 
  Manufacturer: NOVO NORDISK INC
  
  Approval date: December 22, 1997
  
  Strength(s): 0.5MG, 1MG, 2MG ^[RLD]

Has a generic version of Prandin been approved?

No. There is currently no therapeutically equivalent version of Prandin available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Prandin. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.

• 
  NIDDM regimen
  Patent 6,677,358
  Issued: January 13, 2004
  Inventor(s): Peter Giørtz; Müller
  Assignee(s): Novo Nordisk A/S
  The present invention discloses a regimen for the treatment of type 2 diabetes, in which the endogenous secretion of insulin is stimulated in connection with meals, by administering a short-acting, oral hypoglycemic agent. Also, the present invention discloses a method of achieving improvement in glycemic control by combined use of repaglinide and metformin in NIDDM patients poorly controlled on metformin alone.
  
  Patent expiration dates:
  
  
  • June 12, 2018
    
    ✓ 
    Patent use: A METHOD FOR IMPROVING GLYCEMIC CONTROL IN ADULTS WITH TYPE 2 DIABETES MELLITUS
    ✓ 
    Drug substance
    ✓ 
    Drug product
  
  

See also...

• Prandin Consumer Information (Drugs.com)
• Prandin Consumer Information (Wolters Kluwer)
• Prandin Consumer Information (Cerner Multum)
• Prandin Advanced Consumer Information (Micromedex)
• Prandin AHFS DI Monographs (ASHP)
• Repaglinide Consumer Information (Wolters Kluwer)
• Repaglinide Consumer Information (Cerner Multum)
• Repaglinide Advanced Consumer Information (Micromedex)
• Repaglinide AHFS DI Monographs (ASHP)

Spironolactone Altizide Merck

Spironolactone Altizide Merck may be available in the countries listed below.

Ingredient matches for Spironolactone Altizide Merck

Altizide

Altizide is reported as an ingredient of Spironolactone Altizide Merck in the following countries:

• France

Spironolactone

Spironolactone is reported as an ingredient of Spironolactone Altizide Merck in the following countries:

• France

International Drug Name Search

Ketorolaco Trometamina Dany

Ketorolaco Trometamina Dany may be available in the countries listed below.

Ingredient matches for Ketorolaco Trometamina Dany

Ketorolac

Ketorolac tromethamine (a derivative of Ketorolac) is reported as an ingredient of Ketorolaco Trometamina Dany in the following countries:

• Peru

International Drug Name Search

Dormo-Puren

Dormo-Puren may be available in the countries listed below.

Ingredient matches for Dormo-Puren

Nitrazepam

Nitrazepam is reported as an ingredient of Dormo-Puren in the following countries:

• Germany

International Drug Name Search

Vincristina

Vincristina may be available in the countries listed below.

Ingredient matches for Vincristina

Vincristine

Vincristina (DCIT) is known as Vincristine in the US.

International Drug Name Search

Glossary

DCIT	Denominazione Comune Italiana

Click for further information on drug naming conventions and International Nonproprietary Names.

Burgerstein Zinkglukonat

Burgerstein Zinkglukonat may be available in the countries listed below.

Ingredient matches for Burgerstein Zinkglukonat

Zinc Gluconate

Zinc Gluconate is reported as an ingredient of Burgerstein Zinkglukonat in the following countries:

• Switzerland

International Drug Name Search

Budesonid-CT

Budesonid-CT may be available in the countries listed below.

Ingredient matches for Budesonid-CT

Budesonide

Budesonide is reported as an ingredient of Budesonid-CT in the following countries:

• Germany

International Drug Name Search

Betametasona Genfar

Betametasona Genfar may be available in the countries listed below.

Ingredient matches for Betametasona Genfar

Betamethasone

Betamethasone is reported as an ingredient of Betametasona Genfar in the following countries:

• Colombia


• Ecuador

Betamethasone 17α,21-dipropionate (a derivative of Betamethasone) is reported as an ingredient of Betametasona Genfar in the following countries:

• Peru

International Drug Name Search

Grifotenol

Grifotenol may be available in the countries listed below.

Ingredient matches for Grifotenol

Atenolol

Atenolol is reported as an ingredient of Grifotenol in the following countries:

• Chile

International Drug Name Search